Equity Details
Price & Market Data
Price: $1.04
Daily Change: +$0.02 / 1.92%
Daily Range: $1.01 - $1.07
Market Cap: $184,343,551
Daily Volume: 911,655
Performance Metrics
1 Week: -4.59%
1 Month: -18.75%
3 Months: -14.05%
6 Months: -3.70%
1 Year: -5.45%
YTD: -4.59%
About Lucid Diagnostics Inc. (LUCD)
Comprehensive data for Lucid Diagnostics Inc. (LUCD) is available. Current price is 1.04, with a daily change of +$0.02 / 1.92%. Market cap is 184,343,551. View detailed performance metrics for all periods, including YTD, 1-week, 1-month, 3-month, 6-month, and 1-year returns.
Company Details
Employees: 82
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The company's flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.